Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 332

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer

Open access
Ye, Lele, Zhang, Teming, Kang, Zhengchun, Guo, Gangqiang, Sun, Yongji, Lin, Kangming, Huang, Qunjia, Shi, Xinyu, Ni, Zhonglin, Ding, Ning, Zhao, Kong-Nan, Chang, Wenjun, Wang, Junjie, Lin, Feng, Xue, Xiangyang·2019·Frontiers in Immunology

Abstract

Tumor-infiltrating immune cells (TIICs) play essential roles in cancer development and progression. However, the association of TIICs with prognosis in colorectal cancer (CRC) patients remain elusive. Infiltration of TIICs was assessed using ssGSEA and CIBERSORT tools. The association of TIICs with prognosis was analyzed in 1,802 CRC samples date downloaded from the GEO (https://www.ncbi.nlm.nih.gov/geo/) and TCGA (https://gdc.cancer.gov/) databases. Three populations of TIICs, including CD66b+ tumor-associated neutrophils (TANs), FoxP3+ Tregs, and CD163+ tumor-associated macrophages (TAMs) were selected for immunohistochemical validation analysis in 1008 CRC biopsies, and their influence on clinical features and prognosis of CRC patients was analyzed. Prognostic models were constructed based on the training cohort (359 patients). The models were further tested and verified in a testing (249 patients) and validation cohorts (400 patients). Based on ssGSEA and CIBERSORT analysis, the correlation between TIICs and CRC prognosis was inconsistent in different datasets. Moreover, the results with disease-free survival (DFS) and overall survival (OS) data in the same dataset also differed. The high abundance of TIICs found by ssGSEA or CIBERSORT tools can be used for prognostic evaluation effectively. IHC results showed that TANs, Tregs, TAMs were significantly correlated with prognosis in CRC patients and were independent prognostic factors (PDFS ≤ 0.001; POS ≤ 0.023). The prognostic predictive models were constructed based on the numbers of TANs, Tregs, TAMs (C-indexDFS&OS = 0.86; AICDFS = 448.43; AICOS = 184.30) and they were more reliable than traditional indicators for evaluating prognosis in CRC patients. Besides, TIICs may affect the response to chemotherapy. In conclusion, TIICs were correlated with clinical features and prognosis in patients with CRC and thus can be used as markers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2019.02368

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 332

Metadata

Authors
Ye, L., Zhang, T., Kang, Z., Guo, G., Sun, Y., Lin, K., Huang, Q., Shi, X., Ni, Z., Ding, N., Zhao, K.-N., Chang, W., Wang, J., Lin, F., & Xue, X.
Venue
Frontiers in Immunology
Published
2019-10-17
Volume
10
Pages
2368-2368
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2980845005
Cited by
332
References
56
FWCI
12.58
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer. https://app.cochat.ai/papers/10.3389/fimmu.2019.02368
The paper
Ye, L., Zhang, T., Kang, Z., Guo, G., Sun, Y., Lin, K., Huang, Q., Shi, X., Ni, Z., Ding, N., Zhao, K.-N., Chang, W., Wang, J., Lin, F., & Xue, X. (2019). Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2019.02368

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.